Market revenue in 2022 | USD 0.3 million |
Market revenue in 2030 | USD 0.4 million |
Growth rate | 2.7% (CAGR from 2022 to 2030) |
Largest segment | Pcr assay |
Fastest growing segment | Culture Test |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Latex Agglutination Tests, Lateral Flow Assay, PCR Assay, ELISA Tests, Culture Test |
Key market players worldwide | Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc Class A, Abbott Laboratories, ElitechGroup, Seegene, Luminex, Certest Biotec |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to meningitis diagnostic testing market will help companies and investors design strategic landscapes.
Pcr assay was the largest segment with a revenue share of 33.33% in 2024. Horizon Databook has segmented the Norway meningitis diagnostic testing market based on latex agglutination tests, lateral flow assay, pcr assay, elisa tests, culture test covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway meningitis diagnostic testing market , including forecasts for subscribers. This country databook contains high-level insights into Norway meningitis diagnostic testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account